AbbVie (ABBV) Current Assets (2012 - 2026)

AbbVie (ABBV) has 15 years of Current Assets data on file, last reported at $33.5 billion in Q1 2026.

• Current Assets for Q1 2026 came in at $33.5 billion, up 21.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $33.5 billion (up 21.15% YoY), and the FY2025 annual result was $29.1 billion, up 13.6% from the prior year.
• Current Assets climbed to $33.5 billion in Q1 2026 per ABBV's latest filing, from $29.1 billion in the prior quarter.
• Over five years, Current Assets peaked at $38.9 billion in Q1 2024 and troughed at $25.6 billion in Q4 2024.
• A 5-year average of $30.0 billion and a median of $29.1 billion in 2025 frame the typical range for Current Assets.
• The sharpest annual moves came in 2024 and 2025: Current Assets jumped 46.75% in 2024, then decreased 28.8% in 2025.
• A 5-year view of Current Assets shows it stood at $28.5 billion in 2022, then grew by 15.95% to $33.0 billion in 2023, then retreated by 22.48% to $25.6 billion in 2024, then increased by 13.6% to $29.1 billion in 2025, then rose by 15.37% to $33.5 billion in 2026.
• Business Quant data shows ABBV's Current Assets at $33.5 billion in Q1 2026, $29.1 billion in Q4 2025, and $28.5 billion in Q3 2025.